First Eagle Investment Management Portfolio holdings
AUM
$50B
1-Year Return
21.83%
This Quarter Return
+7.79%
1 Year Return
+21.83%
3 Year Return
+77.85%
5 Year Return
+147.97%
10 Year Return
+284.97%
AUM
$36.7B
AUM Growth
+$2.3B
(+6.7%)
Cap. Flow
-$212M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
27.21%
Holding
409
New
50
Increased
120
Reduced
70
Closed
37
Top Buys
| 1 |
Teradata
TDC
|
$383M |
| 2 |
B
Barrick Mining Corporation
B
|
$321M |
| 3 |
Cenovus Energy
CVE
|
$201M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
$200M |
| 5 |
Oracle
ORCL
|
$180M |
Top Sells
| 1 |
FirstEnergy
FE
|
$235M |
| 2 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
$228M |
| 3 |
American Express
AXP
|
$228M |
| 4 |
Northrop Grumman
NOC
|
$225M |
| 5 |
Lockheed Martin
LMT
|
$208M |
Sector Composition
| 1 | Technology | 17.94% |
| 2 | Materials | 15.31% |
| 3 | Financials | 14.44% |
| 4 | Energy | 11.4% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Philip Morris
PM
$251B
| $1.13M | ﹤0.01% |
13,000
-27,000
| -68% | -$2.35M |
|
|
ELLI
202
DELISTED
Ellie Mae Inc
ELLI
| $1.08M | ﹤0.01% |
+40,000
| New | +$1.08M |
|
203
AptarGroup
ATR
$9.12B
| $1.06M | ﹤0.01% |
15,619
| – | – |
|
204
Novartis
NVS
$249B
| $1.05M | ﹤0.01% |
14,575
| – | – |
|
205
Donegal Group Class A
DGICA
$711M
| $1.05M | ﹤0.01% |
+65,919
| New | +$1.05M |
|
206
ResMed
RMD
$40.1B
| $1.04M | ﹤0.01% |
22,000
| – | – |
|
|
SLTM
207
DELISTED
SOLTA MED INC (DE)
SLTM
| $1.03M | ﹤0.01% |
+350,000
| New | +$1.03M |
|
208
Monster Beverage
MNST
$62B
| $1.02M | ﹤0.01% |
90,000
| – | – |
|
209
Gentex
GNTX
$6.17B
| $990K | ﹤0.01% |
60,000
| – | – |
|
|
MTEM
210
DELISTED
Molecular Templates, Inc.
MTEM
| $934K | ﹤0.01% |
1,212
| – | – |
|
|
SPHS
211
DELISTED
Sophiris Bio, Inc.
SPHS
| $925K | ﹤0.01% |
250,000
| – | – |
|
212
Murphy Oil
MUR
$3.67B
| $923K | ﹤0.01% |
14,226
-34,648
| -71% | -$2.25M |
|
213
LKQ Corp
LKQ
$8.31B
| $921K | ﹤0.01% |
28,000
| – | – |
|
214
RTX Corp
RTX
$212B
| $910K | ﹤0.01% |
12,712
-519,730
| -98% | -$37.2M |
|
215
MetLife
MET
$54.4B
| $906K | ﹤0.01% |
18,850
| – | – |
|
216
Bristol-Myers Squibb
BMY
$95B
| $878K | ﹤0.01% |
16,520
| – | – |
|
|
ROYT
217
DELISTED
PACIFIC COAST OIL TRUST
ROYT
| $855K | ﹤0.01% |
67,400
+37,400
| +125% | +$474K |
|
218
Conagra Brands
CAG
$9.07B
| $733K | ﹤0.01% |
27,946
| – | – |
|
219
Inovio Pharmaceuticals
INO
$146M
| $725K | ﹤0.01% |
+5,208
| New | +$725K |
|
220
Telephone and Data Systems
TDS
$4.54B
| $709K | ﹤0.01% |
+27,500
| New | +$709K |
|
221
Merck
MRK
$210B
| $703K | ﹤0.01% |
14,724
-1,173,751
| -99% | -$56M |
|
|
CEQP
222
DELISTED
Crestwood Equity Partners LP
CEQP
| $692K | ﹤0.01% |
+5,000
| New | +$692K |
|
223
Loews
L
$20.2B
| $675K | ﹤0.01% |
14,000
| – | – |
|
224
Exxon Mobil
XOM
$479B
| $671K | ﹤0.01% |
6,628
| – | – |
|
|
ONCY
225
DELISTED
ONCOLYTICS BIOTECH INC
ONCY
| $662K | ﹤0.01% |
427,200
| – | – |
|